| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $34.9M | +44.7% |
| Cost of Revenue | $24.2M | +53.6% |
| Gross Profit | $10.7M | +27.9% |
| R&D Expense | $934K | -49.7% |
| SG&A Expense | $16.5M | +25.6% |
| Operating Income | -$5.8M | -21.5% |
| Pre-tax Income | -$5.4M | -30.6% |
| Income Tax | -$235K | -159.4% |
| Net Income | -$5.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $3.9M | +51.6% |
| Inventory | $11.3M | +96.7% |
| Current Assets | $26.0M | +4.3% |
| Total Assets | $30.6M | +11.8% |
| Current Liabilities | $6.3M | +13.7% |
| Total Liabilities | $7.1M | +15.0% |
| Stockholders' Equity | $23.5M | +10.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.5M | -42.8% |
| Capital Expenditures | $1.7M | +1914.6% |
| Investing Cash Flow | -$2.3M | -253.7% |
| Financing Cash Flow | $9.3M | +171.2% |
| Free Cash Flow | -$14.2M | -60.2% |
| -13.9% |
| EPS (Basic) | -$7.32 | -3752.6% |
| EPS (Diluted) | -$7.32 | -3752.6% |